tiprankstipranks
Alterity Therapeutics Ltd. (PRNAF)
OTHER OTC:PRNAF
US Market
PRNAF
Alterity Therapeutics
RESEARCH TOOLSreports

Alterity Therapeutics (PRNAF) Stock News & Sentiment

5 Followers
Alterity Flags Risks Around Forward‑Looking Corporate Outlook
Premium
Company Announcements
Alterity Flags Risks Around Forward‑Looking Corporate Outlook
4d ago
Alterity Wins FDA Backing on Key Elements of ATH434 Phase 3 Plan
Premium
Company Announcements
Alterity Wins FDA Backing on Key Elements of ATH434 Phase 3 Plan
7d ago
Alterity Therapeutics to Issue 61.5 Million Unlisted Options Under Incentive Plan
Premium
Company Announcements
Alterity Therapeutics to Issue 61.5 Million Unlisted Options Under Incentive Plan
10d ago
Alterity Therapeutics Plans Issue of 150 Million Options on ASX
Premium
Company Announcements
Alterity Therapeutics Plans Issue of 150 Million Options on ASX
17d ago
Alterity Therapeutics Launches Facility to Sell Small Share Parcels
Premium
Company Announcements
Alterity Therapeutics Launches Facility to Sell Small Share Parcels
24d ago
Alterity Therapeutics Highlights Late-Stage Neurodegenerative Pipeline at Bell Potter Summit
Premium
Company Announcements
Alterity Therapeutics Highlights Late-Stage Neurodegenerative Pipeline at Bell Potter Summit
27d ago
Alterity Therapeutics Taps Vanderbilt Neurologist as Chief Medical Advisor Ahead of Phase 3 MSA Trial
Premium
Company Announcements
Alterity Therapeutics Taps Vanderbilt Neurologist as Chief Medical Advisor Ahead of Phase 3 MSA Trial
1M ago
More PRNAF News >

PRNAF News on the Web

Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN)
TipRanks News
Bullish
Alterity gains positive FDA feedback ahead of phase III MSA trial
StockHead
Bullish
Alterity Flags Risks Around Forward‑Looking Corporate Outlook
TipRanks News
Neutral
Alterity Therapeutics receives regulatory feedback from FDA regarding ATH434
TipRanks News
Neutral
Alterity Wins FDA Backing on Key Elements of ATH434 Phase 3 Plan
TipRanks News
Bullish
Alterity Therapeutics to Issue 61.5 Million Unlisted Options Under Incentive Plan
TipRanks News
Bearish
Alterity Therapeutics Plans Issue of 150 Million Options on ASX
TipRanks News
Bearish
ASX healthcare firms deepen university ties to advance new treatments
StockHead
Bullish

News Score - Last 7 Days

Positive
PRNAF
Sector Average
Media Buzz
This Week4 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRNAF’s Media Buzz Sentiment?
4 articles about PRNAF were published this week. In an average week, 2.75 articles are published.
    What is PRNAF’s weekly average amount of articles?
    In an average week, 2.75 articles about PRNAF are published.
      What is PRNAF’s News Sentiment?
      100% of articles about PRNAF were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        2273Gushengtang Holdings Limited
        PALIPalisade Bio
        LTRNLantern Pharma
        Showing the stocks with the most bullish news sentiment over the past week